Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease
{{output}}
Since levodopa-induced peak dyskinesias (LIDs) may reflect, in part, a disproportionate phasic release of dopamine from synaptic vesicles, we examined the ability of the vesicular depletor tetrabenazine (TBZ) to reduce LIDs in 10 dyskinetic advanced Parkinson'... ...
